Dashboard
Manage Tickers

FRST Primis Financial Corp.

Nasdaq primisbank.com


$ 10.67 $ 0.99 (10.21 %)    

Friday, 24-Oct-2025 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 10.69
$ 10.07
$ 9.71 x 500
$ 22.22 x 1
$ 10.04 - $ 10.80
$ 7.44 - $ 12.58
114,055
na
263.44M
$ 0.76
$ 88.82
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-11-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 04-29-2025 12-31-2024 10-K
4 12-11-2024 06-30-2024 10-Q
5 12-11-2024 09-30-2024 10-Q
6 10-25-2024 03-31-2024 10-Q
7 10-15-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 03-15-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 03-14-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-09-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 03-16-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-08-2020 03-31-2020 10-Q
23 03-16-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 03-15-2019 12-31-2018 10-K
28 11-09-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 03-16-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-09-2017 03-31-2017 10-Q
35 03-16-2017 12-31-2016 10-K
36 11-09-2016 09-30-2016 10-Q
37 08-08-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 03-15-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

primis-finl-q3-eps-028-beats-022-estimate-sales-41001m-beat-27961m-estimate
Primis Finl Q3 EPS $0.28 Beats $0.22 Estim...
10/23/2025 21:05:15

Primis Finl (NASDAQ:FRST) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.22 by ...

Core News & Articles
Earnings Scheduled For October 23, 2025
10/23/2025 08:32:24

top-3-financial-stocks-that-are-set-to-fly-this-month
Top 3 Financial Stocks That Are Set To Fly...
08/25/2025 09:41:10

primis-finl-q2-adj-eps-011-misses-021-estimate-sales-43518m-beat-28134m-estimate
Primis Finl Q2 Adj. EPS $0.11 Misses $0.21...
07/24/2025 21:01:58

Primis Finl (NASDAQ:FRST) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.21 b...

Core News & Articles
Earnings Scheduled For July 24, 2025
07/24/2025 08:32:31

top-2-financial-stocks-that-may-rocket-higher-in-q3
Top 2 Financial Stocks That May Rocket Hig...
07/11/2025 12:17:01

primis-financial-expects-to-record-an-additional-gain-of-between-65m-7m-pre-tax-as-the-sales-price-per-share-exceeded-the-carrying-value-as-of-march-31-2025
Primis Financial Expects To Record An Addi...
06/12/2025 18:35:22

primis-financial-reports-signed-non-binding-term-sheet-to-sell-portion-of-its-ownership-in-panacea-financial-holdings-expects-proceeds-of-22m-to-the-company
Primis Financial Reports Signed Non-Bindin...
06/12/2025 18:33:46

Primis Financial Corp. (NASDAQ:FRST) ("Primis" or the "Company") today reported a signed non-binding term sheet...

primis-financia-corp-deconslidated-panacea-financial-holdings-records-pre-tax-gain-of-246m
Primis Financia Corp. Deconslidated Panace...
05/13/2025 20:50:30

this-neurosense-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-3-initiations-for-monday
This NeuroSense Therapeutics Analyst Begin...
05/12/2025 13:20:29

maxim-group-initiates-coverage-on-primis-finl-with-buy-rating-announces-price-target-of-1
Maxim Group Initiates Coverage On Primis F...
05/12/2025 12:38:32

Maxim Group initiates coverage on Primis Finl (NASDAQ:FRST) with a Buy rating and announces Price Target of $1.

primis-finl-q1-adj-eps-014-misses-025-estimate-sales-3412m-beat-2688m-estimate
Primis Finl Q1 Adj. EPS $0.14 Misses $0.25...
04/29/2025 21:03:46

Primis Finl (NASDAQ:FRST) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.25 b...

Core News & Articles
Earnings Scheduled For April 29, 2025
04/29/2025 08:32:27

primis-financial-receives-receipt-of-stay-from-nasdaq-setting-the-hearing-for-thursday-may-15-2025
Primis Financial Receives Receipt Of Stay ...
04/14/2025 21:04:59

As previously disclosed on the Form 8-K dated April 9, 2025, Primis Financial Corp.

primis-financial-corp-receives-nasdaq-notice-about-delayed-10-k-filing
Primis Financial Corp. Receives Nasdaq Not...
04/09/2025 21:06:13

12-financials-stocks-moving-in-thursdays-pre-market-session
12 Financials Stocks Moving In Thursday's ...
04/03/2025 12:05:41

primis-finl-q4-adj-eps-065-may-not-be-comparable-to-011-estimate-sales-3930m-beat-2478m-estimate
Primis Finl Q4 Adj EPS $(0.65) May Not Be ...
01/28/2025 22:32:19

Primis Finl (NASDAQ:FRST) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $0.11 b...

earnings-scheduled-for-january-28-2025
Earnings Scheduled For January 28, 2025
01/28/2025 08:32:12

primis-financial-board-approves-stock-repurchase-program-for-up-to-740600-of-outstanding-shares-of-common-stock
Primis Financial Board Approves Stock Repu...
12/19/2024 22:28:28

The Stock Repurchase Program will begin on December 19, 2024 and conclude on December 19, 2025.

adobe-keros-therapeutics-lovesac-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Adobe, Keros Therapeutics, Lovesac And Oth...
12/12/2024 13:54:11

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION